Home LiteratureArticle Details
PMID: 3880760 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

The Journal of cell biology ·Vol. 100 ·No. 1 ·1985-01-00 ·Pages 86-92

Vassalli JD, Baccino D, Belin D

Abstract

The secretion of plasminogen activators has been implicated in the controlled extracellular proteolysis that accompanies cell migration and tissue remodeling. We found that the human plasminogen activator urokinase (Uk) (Mr 55,000 form) binds rapidly, specifically, and with high affinity to fresh human blood monocytes and to cells of the monocyte line U937. Upon binding Mr 55,000 Uk was observed to confer high plasminogen activator activity to the cells. Binding of the enzyme did not require a functional catalytic site (located on the B chain of the protein) but did require the noncatalytic A chain of Mr 55,000 Uk, since Mr 33,000 Uk did not bind. These results demonstrate the presence of a membrane receptor for Uk on monocytes and show a hitherto unknown function for the A chain of Uk: binding of secreted enzyme to its receptor results in Uk acting as a membrane protease. This localizes plasminogen activation near the cell surface, an optimal site to facilitate cell migration.

MeSH Terms
Binding Sites Cell Line Fluorescent Antibody Technique Humans Kinetics Macrophages/enzymology Molecular Weight Monocytes/enzymology Protein Binding Urokinase-Type Plasminogen Activator/metabolism
Chemicals
Urokinase-Type Plasminogen Activator
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Vassalli J D
Baccino D
Belin D
References (35)
35 references, click to expand
  1. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
    J Exp Med. 1984 Jun 1;159(6):1653-68 PMID: 6374011
  2. Chemotactic response of monocytes to thrombin.
    J Cell Biol. 1983 Jan;96(1):282-5 PMID: 6826648
  3. Content and characterization of plasminogen activators in human lung tumors and normal lung tissue.
    Cancer Res. 1980 Mar;40(3):841-8 PMID: 7193515
  4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Thromb Haemost. 1981 Jun 30;45(3):225-9 PMID: 7025339
  5. Structural relationship between human high and low molecular mass urokinase.
    Hoppe Seylers Z Physiol Chem. 1982 Feb;363(2):133-41 PMID: 7037592
  6. Isolation and characterization of urokinase from human plasma.
    J Biol Chem. 1982 Mar 25;257(6):3276-83 PMID: 7037781
  7. The glomerular permeability determined by dextran clearance using Sephadex gel filtration.
    Scand J Clin Lab Invest. 1968;21(1):77-82 PMID: 5637478
  8. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  9. Plasminogen: purification from human plasma by affinity chromatography.
    Science. 1970 Dec 4;170(3962):1095-6 PMID: 5475635
  10. Protein A from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins.
    FEBS Lett. 1972 Nov 15;28(1):73-6 PMID: 4630462
  11. Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man.
    Proc Natl Acad Sci U S A. 1975 Feb;72(2):474-8 PMID: 164655
  12. Establishment and characterization of a human histiocytic lymphoma cell line (U-937).
    Int J Cancer. 1976 May 15;17(5):565-77 PMID: 178611
  13. Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides.
    Cell. 1976 Jun;8(2):271-81 PMID: 61067
  14. Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm.
    Cell. 1976 Oct;9(2):231-40 PMID: 975245
  15. Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate.
    Cell. 1977 Jul;11(3):695-705 PMID: 884740
  16. Effects of acidified fetal bovine serum on the fibrinolytic activity and growth of cells in culture.
    J Cell Physiol. 1978 Sep;96(3):361-9 PMID: 27528
  17. A study of proteases and protease-inhibitor complexes in biological fluids.
    J Exp Med. 1978 Jul 1;148(1):223-34 PMID: 78958
  18. Specific binding of thrombin by human peripheral blood monocytes: possible role in the clearance of activated clotting factors from the circulation.
    J Lab Clin Med. 1982 Jun;99(6):873-84 PMID: 7077128
  19. Functional prothrombinase complex assembly on isolated monocytes and lymphocytes.
    J Biol Chem. 1983 Jun 25;258(12):7264-7 PMID: 6863244
  20. The regulation of tissue plasminogen activator activity by human fibroblasts.
    Cell. 1983 Aug;34(1):273-9 PMID: 6683996
  21. Antibodies to plasminogen activator inhibit human tumor metastasis.
    Cell. 1983 Dec;35(3 Pt 2):611-9 PMID: 6418388
  22. The insulin receptor of a human monocyte-like cell line: characterization and function.
    Endocrinology. 1984 Jan;114(1):247-53 PMID: 6360663
  23. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    J Clin Invest. 1984 Mar;73(3):806-15 PMID: 6368589
  24. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.
    Cell. 1982 Mar;28(3):653-62 PMID: 6210439
  25. Evidence for membrane association of plasminogen activator activity in mouse macrophages.
    Biochem Biophys Res Commun. 1980 May 30;94(2):480-6 PMID: 7190388
  26. Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system.
    Proc Natl Acad Sci U S A. 1982 Jan;79(2):485-9 PMID: 6952201
  27. A proenzyme form of human urokinase.
    J Biol Chem. 1982 Jun 25;257(12):7262-8 PMID: 6806270
  28. The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain.
    Hoppe Seylers Z Physiol Chem. 1982 Oct;363(10):1155-65 PMID: 6754569
  29. The complete amino acid sequence of low molecular mass urokinase from human urine.
    Hoppe Seylers Z Physiol Chem. 1982 Sep;363(9):1043-58 PMID: 6754572
  30. Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.
    J Clin Invest. 1982 Dec;70(6):1320-3 PMID: 6757269
  31. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.
    Biochemistry. 1982 Dec 7;21(25):6410-5 PMID: 6891264
  32. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.
    Nature. 1983 Jan 20;301(5897):214-21 PMID: 6337343
  33. Importance, localization and functional properties of the cell-associated form of plasminogen activator in mouse peritoneal macrophages.
    Biochim Biophys Acta. 1983 Feb 22;755(3):332-43 PMID: 6681715
  34. The secretion of plasminogen activators by human myeloid leukemic cells in vitro.
    Blood. 1983 Mar;61(3):568-74 PMID: 6572078
  35. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells.
    Cell. 1980 Aug;21(1):37-45 PMID: 6157479
Article Info
Journal
The Journal of cell biology
Abbr.
J Cell Biol
ISSN
0021-9525
Published
1985-01-00
Pages
86-92
Language
English
Region
United States
NLM ID
0375356
PMCID
PMC2113459
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com